Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair.
See omnystudio.com/listener for privacy information.
Create your
podcast in
minutes
It is Free